Hacked by islam_Bey imhatimi.org

GlaxoSmithKline Pharmaceuticals Ltd has announced the following Unaudited results for the quarter ended March 31, 2008:

The Company has posted a net profit of Rs 1212.70 million for the quarter ended March 31, 2008 where as the same was at Rs 1113.20 million for the quarter ended March 31, 2007. Total Income is Rs 4522.10 million for the quarter ended March 31, 2008 where as the same was at Rs 4414.60 million for the quarter ended March 31, 2007.

The growth in Net Sales (excluding the Fine Chemicals business) was 5.3% during the quarter ended March 31, 2008. This performance must be viewed in the context of pipeline inventory adjustments in March 2008 on account of excise-related price changes.

Profit before Tax and Exceptional Items grew by 12.1% during the quarter ended March 31, 2008 on a comparable basis.

The figures for the current period are not comparable with those of the previous period, in view of the sale of the Fine Chemicals business on September 30, 2007.

Tags: GlaxoSmithKline

This entry was posted on Monday, April 21st, 2008 at 10:31 am and is filed under Commodities. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.